Sylvia L Asa Selected Research

Neoplasms (Cancer)

12/2023	Paraganglioma-induced reverse takotsubo syndrome treated with extracorporeal membrane oxygenation in a young patient with a history of malignancy: a case report.
11/2023	Obstacles to Tumor Capsule Assessment in Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP).
11/2023	Divergent Lineage Markers in Anaplastic Thyroid Carcinoma.
9/2023	Multilineage Pituitary Neuroendocrine Tumors (PitNETs) Expressing PIT1 and SF1.
7/2023	Ectopic Cushing's syndrome from a corticotropin-releasing hormone-secreting medullary thyroid carcinoma: a rare pitfall of inferior petrosal sinus sampling.
6/2023	Severe Obesity Associated With Pituitary Corticotroph Hyperplasia and Neoplasia.
4/2023	The Unique Importance of Differentiation and Function in Endocrine Neoplasia.
3/2023	Insights Obtained from the Nontumorous Glandular Tissue in Patients with Endocrine Tumors.
1/2023	Cauda Equina Neuroendocrine Tumors: Distinct Epithelial Neuroendocrine Neoplasms of Spinal Origin.
12/2022	Management of Appendix Neuroendocrine Neoplasms: Insights on the Current Guidelines.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sylvia L Asa Research Topics

Disease

116	Neoplasms (Cancer) 12/2023 - 03/2002
37	Pituitary Neoplasms (Pituitary Adenoma) 11/2019 - 01/2002
30	Thyroid Neoplasms (Thyroid Cancer) 11/2023 - 01/2002
20	Adenoma (Adenomas) 10/2019 - 01/2002
17	Neuroendocrine Tumors (Neuroendocrine Tumor) 04/2023 - 07/2002
14	Carcinoma (Carcinomatosis) 09/2021 - 01/2004
13	Carcinogenesis 11/2021 - 01/2002
11	Paraganglioma (Paragangliomas) 12/2023 - 01/2009
11	Acromegaly 09/2023 - 11/2005
8	Neoplasm Metastasis (Metastasis) 01/2022 - 03/2005
7	Hyperplasia 06/2023 - 10/2002
7	Papillary Thyroid Cancer 01/2021 - 04/2002
7	Pheochromocytoma 01/2021 - 01/2009
6	Pituitary ACTH Hypersecretion 01/2021 - 01/2002
6	Breast Neoplasms (Breast Cancer) 01/2018 - 10/2008
6	Melanoma (Melanoma, Malignant) 12/2010 - 08/2007
5	Cushing Syndrome 07/2023 - 01/2002
5	Parathyroid Neoplasms (Parathyroid Neoplasm) 10/2019 - 11/2002
5	Hypoxia (Hypoxemia) 01/2018 - 01/2009
4	Neuroendocrine Carcinoma 11/2022 - 01/2009
4	Hyperprolactinemia 01/2021 - 07/2006
4	Inflammation (Inflammations) 10/2019 - 02/2006
4	Papillary Carcinoma 01/2019 - 05/2010
4	Thyroid Nodule (Nodule, Thyroid) 01/2018 - 03/2008
4	Multiple Endocrine Neoplasia Type 1 02/2016 - 10/2005
3	Ganglioneuroma 03/2022 - 01/2008
3	Adrenocortical Adenoma (Disease, Conn's) 09/2020 - 01/2009
3	Adrenocortical Carcinoma 06/2018 - 06/2009
3	Testicular Neoplasms (Testicular Cancer) 06/2009 - 08/2007
3	Lymphatic Metastasis 03/2008 - 04/2002
2	Hypertension (High Blood Pressure) 12/2023 - 09/2003
2	Obesity 06/2023 - 07/2013

Drug/Important Bio-Agent (IBA)

32	Hormones (Hormone)IBA 04/2023 - 07/2002
19	Biomarkers (Surrogate Marker)IBA 11/2023 - 10/2012
19	Proteins (Proteins, Gene)FDA Link 11/2021 - 10/2002
17	Adrenocorticotropic Hormone (ACTH)FDA Link 07/2023 - 01/2002
16	Protein Isoforms (Isoforms)IBA 01/2017 - 01/2002
12	Growth Hormone (Somatotropin)IBA 09/2023 - 04/2005
12	Transcription Factors (Transcription Factor)IBA 04/2023 - 01/2002
11	Keratins (Keratin)IBA 01/2023 - 03/2005
10	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 11/2012 - 09/2003
9	ProlactinIBA 09/2023 - 04/2004
9	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 11/2012 - 03/2005
8	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 04/2023 - 11/2005
8	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 09/2003
7	GlucocorticoidsIBA 10/2022 - 04/2005
6	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 09/2023 - 11/2008
6	Hydrocortisone (Cortisol)FDA LinkGeneric 06/2023 - 01/2002
6	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 01/2018 - 06/2007
6	AntigensIBA 01/2016 - 08/2007
6	Messenger RNA (mRNA)IBA 12/2015 - 04/2005
5	CatecholaminesIBA 12/2023 - 09/2003
5	Somatostatin Receptors (Somatostatin Receptor)IBA 04/2023 - 01/2002
5	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2021 - 01/2014
5	Type 4 Fibroblast Growth Factor ReceptorIBA 06/2013 - 05/2003
5	Histones (Histone)IBA 09/2009 - 09/2003
4	Corticotropin-Releasing HormoneIBA 07/2023 - 01/2002
4	IodineIBA 01/2021 - 07/2003
4	Sunitinib (Sutent)FDA Link 01/2019 - 01/2009
4	AntibodiesIBA 06/2018 - 03/2008
4	Insulin (Novolin)FDA Link 03/2018 - 02/2006
4	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 12/2015 - 01/2002
4	Cyclin D1IBA 08/2014 - 04/2002
4	seocalcitolIBA 01/2011 - 02/2002
4	Cadherins (E-Cadherin)IBA 03/2008 - 10/2004
3	Follicle Stimulating Hormone (Follitropin)FDA Link 09/2023 - 11/2008
3	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 07/2023 - 03/2005
3	LipidsIBA 06/2023 - 05/2008
3	Radioisotopes (Radionuclides)IBA 04/2023 - 12/2012
3	Peptide Receptors (Peptide Receptor)IBA 04/2023 - 12/2012
3	EnzymesIBA 04/2023 - 09/2003
3	Chromogranin AIBA 01/2023 - 11/2013
3	CAM 5.2 antigenIBA 01/2023 - 11/2013
3	Thyroglobulin FDA Link 09/2021 - 12/2004
3	CollagenIBA 10/2020 - 09/2015
3	Octreotide (Sandostatin)FDA LinkGeneric 03/2019 - 01/2009
3	CalciumIBA 01/2019 - 11/2002
3	C-terminal binding proteinIBA 01/2018 - 03/2012
3	Tyrosine Kinase InhibitorsIBA 08/2014 - 02/2005
3	Matrix Metalloproteinases (MMPs)IBA 12/2013 - 10/2012
3	OsteopontinIBA 12/2013 - 06/2009
3	Fibronectins (Fibronectin)IBA 04/2012 - 09/2005
3	Vitamin D FDA LinkGeneric 01/2011 - 02/2002
3	CEACAM1 ProteinIBA 01/2011 - 07/2009
3	Cholecalciferol (Vitamin D3)FDA Link 01/2011 - 02/2002
3	Complementary DNA (cDNA)IBA 04/2008 - 10/2004
3	PD 173074IBA 11/2006 - 02/2005
2	Capsules (Microcapsules)IBA 11/2023 - 02/2010
2	Luteinizing Hormone (Lutropin)FDA LinkGeneric 09/2023 - 03/2009
2	Pancreatic Polypeptide (Pancreatic Polypeptide (PP))IBA 01/2023 - 12/2021
2	SynaptophysinIBA 01/2023 - 03/2022
2	GastrinsIBA 01/2023 - 01/2013
2	Glucagon (Glukagon)FDA Link 01/2023 - 12/2021
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 03/2022 - 08/2014

Therapy/Procedure

31	Therapeutics 04/2023 - 01/2002
8	Radiotherapy 01/2021 - 01/2002
4	Drug Therapy (Chemotherapy) 11/2022 - 12/2006
4	Thyroidectomy 01/2019 - 07/2003
3	Adrenalectomy 12/2023 - 01/2009
2	Immunotherapy 11/2022 - 01/2018